Back
Editas Medicine Stock Price Chart

Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
EDIT
Editas Medicine
Last Price:
$1.45
Seasonality Move:
7.98%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.49 | Sell |
20-day SMA: | 1.46 | Sell |
50-day SMA: | 1.42 | Buy |
200-day SMA: | 2.47 | Sell |
8-day EMA: | 1.45 | Sell |
20-day EMA: | 1.4 | Buy |
50-day EMA: | 1.06 | Buy |
200-day EMA: | 0.41 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 51.07 | Buy |
Chaikin Money Flow: | -884662 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.58) | Buy |
Bollinger Bands (100): | (1.13 - 1.71) | Buy |
Editas Medicine Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.45 while EDIT 8-day simple moving average is 1.49, which is a Sell signal.
-
The stock price of EDIT is 1.45 while Editas Medicine 20-day SMA is 1.46, which makes it a Sell.
-
Editas Medicine 50-day simple moving average is 1.42 while EDIT share price is 1.45, making it a Buy technically.
-
EDIT stock price is 1.45 and Editas Medicine 200-day simple moving average is 2.47, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
34
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.45. The Score for EDIT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
120.3M
Price in USD:
1.45
Share Volume:
2.7M
Editas Medicine 52-Week Range
52-Week High:
6.69
52-Week Low:
0.91
Sell
34
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.45 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.45 while EDIT 8-day exponential moving average is 1.45, which is a Sell signal.
-
The stock price of EDIT is 1.45 while Editas Medicine 20-day EMA is 1.40, which makes it a Buy.
-
Editas Medicine 50-day exponential moving average is 1.06 while EDIT share price is 1.45, making it a Buy technically.
-
EDIT stock price is 1.45 and Editas Medicine 200-day simple moving average is 0.41, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.08 per share, and an increase next year of $0.38 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 51.07, which suggest Editas Medicine is overbought
-
The Bollinger Bands (25) for Editas Medicine is (1.18 - 1.58), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is (1.13 - 1.71), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.